drugset / Trial / NCT05389995

Potassium Citrate and Crystal Light Lemonade

NCT05389995

Active not recruiting 10 enrolled Northwestern University
RandomizedCrossoverOpen-labelTreatment

Summary

To define the effect of crystal light, potassium citrate, or both on urinary stone risk factors in patients with a history of stone and hypocitraturia/low pH

Timeline

Start
2022-08-01
Primary completion
2025-04-01
Completion
2027-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator POTASSIUM CITRATE ANHYDROUS Small molecule

Indications